Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Dow Inc
DOW
|
+$123M |
| 2 |
Newmont
NEM
|
+$77.1M |
| 3 |
Corteva
CTVA
|
+$72.5M |
| 4 |
Amcor
AMCR
|
+$60.2M |
| 5 |
Alibaba
BABA
|
+$47.4M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$101M |
| 2 |
Apple
AAPL
|
+$94.5M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$77.6M |
| 5 |
Pfizer
PFE
|
+$53.9M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.13% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EBIX
1601
DELISTED
Ebix Inc
EBIX
| $2.34M | ﹤0.01% |
46,600
+6,700
| +17% | +$336K |
|
|
POLY
1602
DELISTED
Plantronics, Inc.
POLY
| $2.31M | ﹤0.01% |
62,400
+700
| +1% | +$25.9K |
|
|
FOE
1603
DELISTED
Ferro Corporation
FOE
| $2.31M | ﹤0.01% |
146,200
+2,100
| +1% | +$33.2K |
|
|
SASR
1604
DELISTED
Sandy Spring Bancorp Inc
SASR
| $2.31M | ﹤0.01% |
66,135
+4,600
| +7% | +$160K |
|
|
ATRI
1605
DELISTED
Atrion Corp
ATRI
| $2.3M | ﹤0.01% |
2,702
| – | – |
|
1606
Inogen
INGN
$231M
| $2.3M | ﹤0.01% |
34,500
+1,200
| +4% | +$80.1K |
|
1607
G-III Apparel Group
GIII
$1.15B
| $2.3M | ﹤0.01% |
78,100
+1,900
| +2% | +$55.9K |
|
1608
Clearway Energy Class C
CWEN
$3.37B
| $2.3M | ﹤0.01% |
136,250
+3,000
| +2% | +$50.6K |
|
1609
Sleep Number
SNBR
$234M
| $2.29M | ﹤0.01% |
56,800
-3,700
| -6% | -$149K |
|
1610
AMERISAFE
AMSF
$862M
| $2.29M | ﹤0.01% |
35,900
+700
| +2% | +$44.6K |
|
1611
CRISPR Therapeutics
CRSP
$5.08B
| $2.29M | ﹤0.01% |
48,600
+10,800
| +29% | +$509K |
|
1612
Enanta Pharmaceuticals
ENTA
$185M
| $2.29M | ﹤0.01% |
27,100
+600
| +2% | +$50.6K |
|
|
BRKL
1613
DELISTED
Brookline Bancorp
BRKL
| $2.28M | ﹤0.01% |
148,400
+1,700
| +1% | +$26.1K |
|
1614
AAR Corp
AIR
$2.71B
| $2.28M | ﹤0.01% |
62,000
+1,300
| +2% | +$47.8K |
|
1615
AeroVironment
AVAV
$12.1B
| $2.28M | ﹤0.01% |
40,100
+800
| +2% | +$45.4K |
|
|
OSB
1616
DELISTED
Norbord Inc.
OSB
| $2.28M | ﹤0.01% |
91,828
+21,400
| +30% | +$530K |
|
|
WIRE
1617
DELISTED
Encore Wire Corp
WIRE
| $2.28M | ﹤0.01% |
38,833
+700
| +2% | +$41K |
|
1618
Helix Energy Solutions
HLX
$932M
| $2.27M | ﹤0.01% |
263,000
+6,500
| +3% | +$56.1K |
|
1619
OFG Bancorp
OFG
$1.97B
| $2.27M | ﹤0.01% |
95,500
+2,100
| +2% | +$49.9K |
|
1620
Sangamo Therapeutics
SGMO
$160M
| $2.27M | ﹤0.01% |
210,360
+24,300
| +13% | +$262K |
|
1621
Constellium
CSTM
$2.09B
| $2.26M | ﹤0.01% |
225,300
+4,600
| +2% | +$46.2K |
|
1622
Warrior Met Coal
HCC
$3.11B
| $2.26M | ﹤0.01% |
86,400
+19,100
| +28% | +$499K |
|
1623
Brookdale Senior Living
BKD
$1.77B
| $2.25M | ﹤0.01% |
312,539
-29,600
| -9% | -$213K |
|
1624
Upbound Group
UPBD
$1.48B
| $2.25M | ﹤0.01% |
84,600
+11,500
| +16% | +$306K |
|
1625
Seaboard Corp
SEB
$3.78B
| $2.25M | ﹤0.01% |
543
+9
| +2% | +$37.2K |
|